181 related articles for article (PubMed ID: 38576048)
21. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
22. H3K27me3 demethylase UTX regulates the differentiation of a subset of bipolar cells in the mouse retina.
Umutoni D; Iwagawa T; Baba Y; Tsuhako A; Honda H; Aihara M; Watanabe S
Genes Cells; 2020 Jun; 25(6):402-412. PubMed ID: 32215989
[TBL] [Abstract][Full Text] [Related]
23. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
24. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells.
Cribbs A; Hookway ES; Wells G; Lindow M; Obad S; Oerum H; Prinjha RK; Athanasou N; Sowman A; Philpott M; Penn H; Soderstrom K; Feldmann M; Oppermann U
J Biol Chem; 2018 Feb; 293(7):2422-2437. PubMed ID: 29301935
[TBL] [Abstract][Full Text] [Related]
25. Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX.
Arcipowski KM; Martinez CA; Ntziachristos P
Curr Opin Genet Dev; 2016 Feb; 36():59-67. PubMed ID: 27151432
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation.
Kania AK; Guo M; Scharer CD; Boss JM
Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105
[TBL] [Abstract][Full Text] [Related]
27. Comparative expression analysis of the H3K27 demethylases, JMJD3 and UTX, with the H3K27 methylase, EZH2, in Xenopus.
Kawaguchi A; Ochi H; Sudou N; Ogino H
Int J Dev Biol; 2012; 56(4):295-300. PubMed ID: 22562205
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
29. Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer.
Morozov VM; Li Y; Clowers MM; Ishov AM
Oncotarget; 2017 Sep; 8(37):62131-62142. PubMed ID: 28977932
[TBL] [Abstract][Full Text] [Related]
30. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.
Jia W; Wu W; Yang D; Xiao C; Su Z; Huang Z; Li Z; Qin M; Huang M; Liu S; Long F; Mao J; Liu X; Zhu YZ
FASEB J; 2018 Jul; 32(7):4031-4042. PubMed ID: 29481307
[TBL] [Abstract][Full Text] [Related]
31. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
32. The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives.
Xiao ZG; Shen J; Zhang L; Li LF; Li MX; Hu W; Li ZJ; Cho CH
Curr Med Chem; 2016; 23(32):3687-3696. PubMed ID: 27458035
[TBL] [Abstract][Full Text] [Related]
33. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
Romero OA; Vilarrubi A; Alburquerque-Bejar JJ; Gomez A; Andrades A; Trastulli D; Pros E; Setien F; Verdura S; Farré L; Martín-Tejera JF; Llabata P; Oaknin A; Saigi M; Piulats JM; Matias-Guiu X; Medina PP; Vidal A; Villanueva A; Sanchez-Cespedes M
Nat Commun; 2021 Jul; 12(1):4319. PubMed ID: 34262032
[TBL] [Abstract][Full Text] [Related]
34. H3K27 demethylases are dispensable for activation of Polycomb-regulated injury response genes in peripheral nerve.
Duong P; Ma KH; Ramesh R; Moran JJ; Won S; Svaren J
J Biol Chem; 2021 Jul; 297(1):100852. PubMed ID: 34090875
[TBL] [Abstract][Full Text] [Related]
35. H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.
Park WY; Hong BJ; Lee J; Choi C; Kim MY
Cancer Res; 2016 Jan; 76(1):161-70. PubMed ID: 26729791
[TBL] [Abstract][Full Text] [Related]
36. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
37. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
[TBL] [Abstract][Full Text] [Related]
38. Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation.
Hübner MR; Spector DL
Cold Spring Harb Symp Quant Biol; 2010; 75():43-9. PubMed ID: 21209387
[TBL] [Abstract][Full Text] [Related]
39. JMJD3 downregulates IL4i1 aggravating lipopolysaccharide-induced acute lung injury via H3K27 and H3K4 demethylation.
Gao Y; Wang N; Jia D
Environ Toxicol; 2023 Mar; 38(4):754-769. PubMed ID: 36537648
[TBL] [Abstract][Full Text] [Related]
40. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X
J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
